卵巢癌女性遗传学评估的差异:我们能做得更好吗?
该研究通过病理报告识别2012年8月至2016年1月诊断的246例卵巢癌患者,回顾性分析遗传咨询转诊和完成率。结果显示53%被转诊,36%完成咨询,33%完成基因检测;转诊率在种族和保险类型间存在显著差异。作者认为尚未达到妇科肿瘤学会推荐的转诊标准,建议关注这些障碍。
要点
- 246例卵巢癌患者中53%被转诊遗传咨询,36%完成咨询,33%完成基因检测。
- 转诊率因种族而异:白人61%,亚裔40%,拉丁裔38%,黑人33%(p=0.035)。
- 英语语言(p<0.0001)、高级别浆液性组织学(p<0.0001)和私人或Medicare保险(p<0.0001)与转诊显著相关。
核心结论
- 研究尚未达到妇科肿瘤学会推荐的遗传学转诊标准;有色人种和公共保险者转诊率较低,作者建议关注外展和口译服务等障碍。
研究设计与样本
- 回顾性研究,通过2012年8月至2016年1月病理报告含「浆液性」或「卵巢」字样识别246例卵巢癌女性,排除10例既往已咨询者,通过电子病历获取信息。
主要发现
- 53%的患者被转诊遗传咨询,从诊断到咨询的平均时间为4.6个月。
- 年龄和家族史与转诊无关;转诊率因种族而异:白人61%,亚裔40%,拉丁裔38%,黑人33%(p=0.035)。
- 36%的患者完成咨询,33%完成基因检测。
- 英语语言(p<0.0001)、高级别浆液性组织学(p<0.0001)和私人或Medicare保险(p<0.0001)与转诊显著相关。
临床怎么用
- 作者建议关注外展和口译服务等障碍,以提供包括遗传学评估在内的综合肿瘤诊疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We sought to characterize referral patterns for genetic counseling for women with ovarian cancer and hypothesized that differences in referral and testing rates are shaped by socioeconomic factors. METHODS: Patients were identified by pathology reports from August 2012 to January 2016 containing the words "serous" or "ovarian." Patient information was obtained via electronic medical record. Primary outcomes were placement of a genetics referral and completion of counseling. A secondary outcome was completion of genetic testing. RESULTS: We identified 246 women with a diagnosis of ovarian cancer. Ten were previously counseled and excluded. 53% of patients were referred for counseling with mean time from diagnosis to counseling of 4.6months. Age and family history were not associated with referral, however rates differed by race with 61% of Caucasian and 40%, 38% and 33% of Asian, Latina and Black women, respectively, referred (p=0.035). Overall, 36% of patients diagnosed underwent counseling, and 33% were tested. English language (p<0.0001), high-grade serous histology (p=<0.0001) and private or Medicare insurance (p<0.0001) were significantly associated with referral. CONCLUSION: We have not yet reached the Society of Gynecologic Oncology recommendation for referral to genetics. Women of color and those with public insurance have lower referral rates. This disparity in care impacts cancer treatment options and prevents appropriate screening for other hereditary malignancies. To provide comprehensive oncology care, including genetic assessment, we recommend focusing on these barriers including improving outreach and interpreter services.
引用
- Manrriquez E, Chapman JS, Mak J, et al. Disparities in genetics assessment for women with ovarian cancer: Can we do better? Gynecol Oncol. 2018. PMID: 29605055. doi:10.1016/j.ygyno.2017.10.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。